Results
1216
Companies which are more than 50% undervalued based on analyst price target.
1,216 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BIIB | US$149.02 | 1.1% | -42.8% | US$21.7b | US$244.02 | PE13.4x | E13.6% | n/a | Pharmaceuticals & Biotech | ||
DVN | US$31.24 | 2.4% | -31.7% | US$20.5b | US$50.12 | PE6x | E-4.7% | 4.6% | Energy | ||
BGNE | US$181.62 | 3.9% | 1.2% | US$19.3b | US$280.92 | PS6x | E73.3% | n/a | Pharmaceuticals & Biotech | ||
MDB | US$243.00 | -0.8% | -41.7% | US$18.1b | US$379.30 | PS9.4x | E12.6% | n/a | Software | ||
MRNA | US$40.27 | 1.8% | -59.2% | US$15.5b | US$74.19 | PS3x | E16.0% | n/a | Pharmaceuticals & Biotech | ||
RPRX | US$25.23 | 3.9% | -9.8% | US$14.9b | US$41.53 | PE9.8x | E6.3% | 3.3% | Pharmaceuticals & Biotech | ||
SMMT | US$19.00 | 3.3% | 571.4% | US$14.0b | US$33.13 | PB32x | E-2.7% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$121.90 | 2.0% | 24.7% | US$11.6b | US$185.10 | PE95.6x | E43.0% | n/a | Pharmaceuticals & Biotech | ||
PCVX | US$85.91 | -0.3% | 35.7% | US$10.7b | US$149.89 | PB3.1x | E-4.5% | n/a | Pharmaceuticals & Biotech | ||
VFS | US$4.22 | 2.7% | -51.2% | US$9.9b | US$6.33 | PS6.7x | E-5.8% | n/a | Automobiles | ||
ASTS | US$23.49 | 2.1% | 280.1% | US$8.6b | US$35.94 | PS2616.9x | E78.5% | n/a | Telecom | ||
RVMD | US$44.39 | 2.5% | 51.1% | US$7.5b | US$73.00 | PS10063.7x | E7.2% | n/a | Pharmaceuticals & Biotech | ||
CZR | US$33.33 | -1.6% | -29.3% | US$7.1b | US$53.09 | PS0.6x | E67.3% | n/a | Consumer Services | ||
CHRD | US$113.18 | 2.5% | -32.3% | US$6.9b | US$181.94 | PE7.4x | E0.6% | 9.0% | Energy | ||
XP | US$12.12 | 0.2% | -54.0% | US$6.5b | US$21.29 | PE9.4x | E12.0% | 9.4% | Diversified Financials | ||
LEGN | US$32.80 | -3.6% | -45.2% | US$6.0b | US$81.85 | PS11.6x | E69.1% | n/a | Pharmaceuticals & Biotech | ||
IONS | US$36.53 | 2.6% | -27.7% | US$5.8b | US$61.36 | PS7.2x | E32.4% | n/a | Pharmaceuticals & Biotech | ||
CYTK | US$48.53 | 3.8% | -41.7% | US$5.7b | US$81.71 | PS1779.2x | E36.8% | n/a | Pharmaceuticals & Biotech | ||
TX | US$28.88 | -0.6% | -32.3% | US$5.7b | US$44.27 | PE71.4x | E47.9% | 11.4% | Materials | ||
TEM | US$34.79 | 5.3% | n/a | US$5.5b | US$59.56 | PS8.6x | E38.5% | n/a | Pharmaceuticals & Biotech | ||
BBIO | US$28.53 | 8.9% | -31.8% | US$5.4b | US$48.89 | PS24.8x | E26.1% | n/a | Pharmaceuticals & Biotech | ||
DAR | US$33.70 | 0.2% | -32.9% | US$5.4b | US$51.70 | PE20.5x | E29.9% | n/a | Food, Beverage & Tobacco | ||
CHX | US$26.62 | 2.7% | -10.2% | US$5.1b | US$42.25 | PE16.1x | E10.1% | 1.4% | Energy | ||
GXO | US$42.26 | -1.2% | -32.0% | US$5.0b | US$68.00 | PE47.2x | E44.7% | n/a | Transportation |